Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | NOX1 | Q9Y5S8 | 3/20 | 0.51 |
| ▸ | CYBB | P04839 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | NOX3 | Q9HBY0 | 1/20 | 0.51 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27794501 | 0.85 | SRD5A2 (0.58) | MAPTMEN1KMT2ALMNAL3MBTL1 | |
| SCHEMBL7681194 | 0.84 | ALDH1A1 (0.44) | MAPTMEN1KMT2ANOX1CYBB | |
| SCHEMBL23648301 | 0.83 | TRPA1 (0.53) | MAPTMEN1KMT2AALOX15LMNA | |
| SCHEMBL10848340 | 0.83 | HDAC8 (0.41) | MAPTNPC1RAB9AMEN1KMT2A | |
| Thioxanthene SCHEMBL11865022 | 0.81 | ALDH1A1 (0.53) | MAPTMEN1KMT2ANOX1LMNA | |
| SCHEMBL2129616 | 0.79 | MAPT (0.65) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL27791546 | 0.77 | ALDH1A1 (0.49) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL10791216 | 0.77 | TRPA1 (0.45) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL10710400 | 0.77 | TSHR (0.46) | MEN1KMT2ALMNAALDH1A1HPGD | |
| SCHEMBL9681571 | 0.75 | SRD5A2 (0.54) | MAPTMEN1KMT2ALMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3498691-B1 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD (CN) | 2021-07-07 | — | — | EP | disclosed |
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2019-07-18 | — | — | US | disclosed |
| EP-3498691-A1 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | Changzhou Tronly New Electronic Materials Co., Ltd (CN) | 2019-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | SLC11A2, SLC7A1, PPOX | MAPT 1573/4885NPC1 337/4885RAB9A 409/4885 |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | SLC11A2, SLC7A1, PPOX | MAPT 1723/4885NPC1 301/4885RAB9A 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.